News
When it comes to relapsed/refractory follicular lymphoma, chimeric antigen receptor (CAR) T-cell therapy has become a go-to ...
Researchers say they've discovered an already approved migraine drug that can stop symptoms hours before a severe headache ...
The U.S. Federal Drug Administration (FDA) has granted Incyclix Bio Fast Track designation for INX-315 to treat ...
Financial toxicity can affect patient outcomes and quality of life. For example, a patient may forgo treatment or medications ...
Cardiff Oncology is entering a pivotal stage with a strong cash runway and compelling early data in first-line RAS-mutant ...
Montana just passed a new bill backed by longevity enthusiasts that will enable access to drugs and therapies that are not ...
Abeona Therapeutics Inc. (Nasdaq: ABEO) and Ann & Robert H. Lurie Children’s Hospital of Chicago today announced that Lurie Children’s is now activated as the first Qualified Treatment Center (QTC) ...
A Davie mom fighting a rare and rapidly spreading cancer is enrolled in a pioneering clinical trial at Memorial Cancer ...
Weight-loss drugs and bariatric surgery both have an impact on cancer risk. A new study breaks down the link and how GLP-1 ...
The FDA has approved Teal Health's at-home test for HPV detection, which may help expand access to cervical cancer screening ...
The FDA has granted Orphan Drug designation to TPST-1495, dual receptor inhibitor of prostaglandin signaling, for the treatment of familial adenomatous polyposis.
The U.S. Food and Drug Administration said on Tuesday it is starting a process to remove fluoride supplements for children ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results